Piotr Serwatowski
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 10%
- Immunology top 5%
- Cancer Research top 5%
- Co-authors
- U. GatzemeierJoachim von PawelJohan VansteenkisteRaju Titus ChackoMartin ReckIgor BondarenkoThomas J. LynchFabrice Barlési
- Topics
- Lung Cancer Treatments and Mutations (17 papers)Lung Cancer Research Studies (12 papers)Lung Cancer Diagnosis and Treatment (10 papers)
- Partner nations
- GermanyUnited StatesPoland
In The Last Decade
Piotr Serwatowski
28 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 4.0k
- Pulmonary and Respiratory Medicine 3.5k
- Molecular Biology 1.0k
- Immunology 760
- Cancer Research 626
Countries citing papers authored by Piotr Serwatowski
This map shows the geographic impact of Piotr Serwatowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Serwatowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Serwatowski more than expected).
Fields of papers citing papers by Piotr Serwatowski
This network shows the impact of papers produced by Piotr Serwatowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Serwatowski. The network helps show where Piotr Serwatowski may publish in the future.
Co-authorship network of co-authors of Piotr Serwatowski
This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Serwatowski. A scholar is included among the top collaborators of Piotr Serwatowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Serwatowski. Piotr Serwatowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 9 | |
| 5 | 18 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 37 | |
| 9 | 2 | |
| 10 | Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trialbreakdown → | 500 |
| 11 | Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Studybreakdown → | 816 |
| 12 | 117 | |
| 13 | 32 | |
| 14 | Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancerbreakdown → | 2487 |
| 15 | 35 | |
| 16 | 9 | |
| 17 | Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trialbreakdown → | 706 |
| 18 | 27 | |
| 19 | 3 | |
| 20 | [Analysis of course and treatment results after treatment of pulmonary tuberculosis with early introduction of interrupted observation--preliminary report]. | 1 |
About Piotr Serwatowski
Piotr Serwatowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 28 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (12 papers) and Lung Cancer Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (4.0k citations), Pulmonary and Respiratory Medicine (3.5k citations) and Cancer Research (626 citations). Piotr Serwatowski has collaborated with scholars based in Germany, United States and Poland. Frequent co-authors include U. Gatzemeier, Joachim von Pawel, Johan Vansteenkiste, Raju Titus Chacko, Martin Reck, Igor Bondarenko, Thomas J. Lynch, Fabrice Barlési, Christian Manegold and Giorgio V. Scagliotti. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.